| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.072 | 0.02 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |